“Keep it Simple Stupid!” The medical field has been swept up in a revolution of scientific discovery. With the advent of unlocking the secrets of life, encoded within our DNA, the link between research and clinical practice has been skewed. Sales hype and the perceived potential for profits, differentiation and marketing claims make untested medical breakthroughs part of the sales professionals pitch. “The Shameful State of Our Hospitals” (http://www.beckershospitalreview.com/hospital-management-administration/chuck-lauer-keep-it-simple.html) written by Chuck Lauer, regarding the need to get back to basics site many instances where getting back to basics can vastly improve the state of healthcare. I was told of the KISS principle early on in my career, and I’ve always focused on accomplishing the “Task at Hand”. As technology and medical science advances, it is increasingly hard to maintain that focus, but if you break down complicated tasks, into “bite sized” pieces, it’s easier to make step-wise progress to your end goal.
Whether meeting quota’s, validating tests, products and services, maintaining organizational integrity or C-suite titles are motivating factors in peoples aspirations, the bottom line, as it relates to healthcare, is the patient. Without exception, the importance of the patient is always the ultimate focus of the mission statements of all the companies I’ve ever been involved in. Profits are certainly important, as this is the mothers milk of success and the driving force in order to keep moving forward. When a product or service goes to the bottom line, “the patient”, it makes it all worthwhile, and profits follow.
All that said, the discovery of new genes that govern biological processes, and our ability to investigate these, do hold the potential of improving the lives for those afflicted with specific problems. The FDA as well as our elected officials in Washington, have the sacred task of regulating what is, and is not worth moving forward. Whether it’s FDA approval or government and business subsidy and sponsorship, moving these technologies forward should be dependent on how these discoveries advance the ultimate cause; the patient.
Personalized medicine has been a buzzword that has been used to represent the potential of improved outcomes. To corporate executives and business leaders it actually represents increased sales and profits. In a world of “out of control” healthcare costs, we all need to get back to basics and keep it simple. The pediatrician who treated our children used to always say, “my kids had this, and I did, so and so…”, and I was upset that she wasn’t being scientific, but in retrospect, our kids turned out just fine, and looking back, her approach to the practice of medicine was simple and effective. In large part, that’s what we, in the medical community, need to get back to.
Focus on specific details of everyday activities and help move projects forward. Focus and succeed!!!! And Keep it Simple Stupid.